ADL BIONATUR SOLUTIONS

Trading sesion


07/07/2020 Close

1.0000

Last price


39.39 mill. €

Capitalisation

-5.66

Dif.(%)


-50.98

% Year 2020

Last Trade

Date

07/07/2020

Hour

Close

Last

1.0000

Ref.

1.0600

Dif.(%)

-5.66

Volume (Shares)

34,211

Turnover (€x1000)

34.77

X
07/07/2020 17:37:22
BidAsk
OrdersVolumePricePriceVolumeOrders
14250.98201.00004661
16000.98001.03001,2001
16250.95601.04001,2501
15000.95401.05001,2501
- - - 1.06004901

Security

Security name

ADL BIONATUR SOLUTIONS

Ticker

ADL

ISIN

ES0184980003

NIF

A-11811163

Shares Admitted

39.389.067

Nominal

0,05 Euros

Capital Admitted

1.969.453,35 Euros

Trading

Continuo

Liquidity Provider

AURIGA GLOBAL INVESTORS S.V., S.A.

Registered Advisor

IMPULSA CAPITAL S.L.

Auditor

ERNST & YOUNG S.L.

Address

AV DESARROLLO TECNOLOGICO 11, JEREZ DE LA FRONTERA

Contact

ir@adlbionatur.com

Historical Summary

 20162017201820192020 until 7/07

Capital Admitted (thousands of euros)

2552551,9691,9691,969

Shares (x 1,000)

5,0905,09039,38939,38939,389

Period Close Price (euros)

3.11002.98001.67002.04001.0000

Period Last Price (euros)

3.11002.98001.67002.04001.0000

Period High Price (euros)

5.23003.96003.68002.50002.2800

Period Low Price (euros)

2.65001.40001.58001.63001.0000

Capitalisation (thousands of euros)

15,83015,16965,78080,35439,389

Volume (thousands of shares)

4269752,7133,6981,827

Turnover (thousands of euros)

1,6082,4796,2357,7593,057

Company Profile

Bionaturis is a biotechnology-based group offering premium solutions for human and animal health applications. The Biotech Group comprises 4 companies (Bionaturis, Biobide, ZIP Solutions, and BNT Pacific LTD) and 2 subsidiaries (BNT China Biosciences and Biobide USA) located in three different continents, being worldwide references in their markets.

The matrix company of the Group, Bionaturis -Jerez de la Frontera, Cadiz-, is devoted to Animal Health, where is positioned as a partner of choice to bring high profitable products and services to the market place. By a B2B business model Bionaturis co-develops best-in-class prescription and non-prescription products for food production animals (FPAs) and pets. Cutting-edge antigens, probiotics and feed additives, among others, are part of the broad portfolio of products to meet the main needs of a steady growing sector.

Biobide -San Sebastian- is a preclinical CRO (Contract Research Organization) worldwide leader in the use of zebrafish as animal model for efficacy and toxicity assays for the Pharma, cosmetic, nutraceutical, agri-food, and environmental sectors.

ZIP Solutions –Barcelona- is a leading company in bioprocess having a relevant portfolio of international patents around its two main assets: Splittera and Zera Vaccines (subunit 2.0 and DNA vaccines). Its business model is based on the license of its proprietary systems to tier 1 companies in the sector.

Other Relevant Information

Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.